Screening mammography – early detection or over-diagnosis? Contribution from Australian data

References

• Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011: CD001877
   Web of Science ®Google Scholar
• Harris R, Yeatts J, Kinsinger L. Breast cancer screening for women ages 50 to 69 years: a systematic review of observational evidence. Prev Med 2011;53:108–14
   PubMed Web of Science ®Google Scholar
• Jorgensen KJ. Flawed methods explain the effect of mammography screening in Nijmegen. Br J Cancer 2011;105:592–593
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer. Breast Cancer Screening. Lyon, France: IARC, 2002
   Google Scholar
• Independent UK panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012;380:1778–86
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). BreastScreen Australia Monitoring Report 2009–2010. Cancer series no. 72. Cat. no. CAN 68. Canberra: AIHW, 2012
   Google Scholar
• Burton RC, Bell RJ, Thiagarajah G, et al. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991. Breast Cancer Res Treat 2012;131:949–55
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). Australian Cancer Incidence and Mortality. Canberra: AIHW, 2014
   Google Scholar
• Cancer Research UK. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast/mortality/uk-breast-cancer-mortality-statistics#trends
   Google Scholar
• National Cancer Institute. http://seer.cancer.gov/statfacts/html/breast.html
   Google Scholar
• Bosetti C, Bertuccio P, Levi F, et al. The decline in breast cancer mortality in Europe: an update (to 2009). Breast 2012; 21:77–82
   PubMed Web of Science ®Google Scholar
• European Cancer Organisation. http://www.ecco-org.eu/Global/News/EBCC9-PR/2014/03/Autier-Deaths-from-breast-cancer-fall-in-Europe.aspx
   Google Scholar
• Nyström L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909–19
   PubMed Web of Science ®Google Scholar
• Giles GG, Amos A. Evaluation of the organised mammographic screening programme in Australia. Ann Oncol 2003;14: 1209–11
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687–717
   PubMed Web of Science ®Google Scholar
• Davies C, Godwin J, Gray R, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 2011;378:771–84
   PubMed Web of Science ®Google Scholar
• Hill DJ, Giles GG, Russell IS, et al. Management of primary, operable breast cancer in Victoria. Med J Aust 1990;152:67–72
   PubMed Web of Science ®Google Scholar
• Byrne MJ, Jamrozik K, Parsons RW, et al. Breast cancer in Western Australia in 1989. II. Diagnosis and primary management. ANZ J Surg 1993;63:7–23
   Google Scholar
• Hill DJ, Jamrozik K, White VM, et al. Surgical Management of Breast Cancer in Australia in 1995. Kings Cross, NSW: National Breast Cancer Centre, 1999
   Google Scholar
• White V, Pruden M, Giles G, et al. The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 2004;101:476–85
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411
   PubMedGoogle Scholar
• Miller AB. Conundrums in screening for cancer. Int J Cancer 2010;126:1039–46
   PubMed Web of Science ®Google Scholar
• Miller AB, Wall C, Baines CJ, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ 2014;348:g366
   PubMed Web of Science ®Google Scholar
• Jatoi I. The impact of advances in treatment on the efficacy of mammography screening. Prev Med 2011;53:103–4
   PubMed Web of Science ®Google Scholar
• Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784–92
   PubMed Web of Science ®Google Scholar
• Gann PH. Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology 1997;8:117–20
   PubMed Web of Science ®Google Scholar
• Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302:1685–92
   PubMed Web of Science ®Google Scholar
• Drukker CA, Schmidt MK, Rutgers EJ, et al. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res Treat 2014;144:103–11
   PubMed Web of Science ®Google Scholar
• Esserman LJ, Shieh Y, Rutgers EJ, et al. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 2011;130:725–34
   PubMedGoogle Scholar
• Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012; 367:1998–2005
   PubMed Web of Science ®Google Scholar
• Lousdal ML, Kristiansen IS, Moller B, et al. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. Eur J Public Health 2014 March 4. Epub ahead of print
   Google Scholar
• Autier P, Boniol M, Middleton R, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 2011;22:1726–35
   PubMed Web of Science ®Google Scholar
• Foca F, Mancini S, Bucchi L, et al. Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy. Cancer 2013;119:2022–8
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare and Cancer Australia. Breast Cancer in Australia: an Overview. Canberra, 2012
   Google Scholar
• Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer 2013;108:1195–208
   PubMed Web of Science ®Google Scholar
• Cheung P, Hung WK, Cheung C, et al. Early data from the first population-wide breast cancer-specific registry in Hong Kong. World J Surg 2012;36:723–9
   PubMed Web of Science ®Google Scholar
• Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605–13
   PubMed Web of Science ®Google Scholar
• Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7:230–4
   PubMed Web of Science ®Google Scholar
• Zackrisson S, Andersson I, Janzon L, et al. Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. BMJ 2006;332:689–92
   PubMed Web of Science ®Google Scholar
• Zahl PH, Strand BH, Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921–4
   PubMed Web of Science ®Google Scholar
• Biesheuvel C, Barratt A, Howard K, et al. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007;8:1129–38
   PubMed Web of Science ®Google Scholar
• Duffy SW, Parmar D. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res 2013;15:R41
   PubMed Web of Science ®Google Scholar
• Puliti D, Miccinesi G, Paci E. Overdiagnosis in breast cancer: design and methods of estimation in observational studies. Prev Med 2011;53:131–3
   PubMed Web of Science ®Google Scholar
• Zahl PH, Jorgensen KJ, Gotzsche PC. Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer 2013;109:2014–19
   PubMed Web of Science ®Google Scholar
• Puliti D, Duffy SW, Miccinesi G, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen 2012;19(Suppl 1):42–56
   PubMedGoogle Scholar
• Jorgensen KJ, Gotzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587
   PubMed Web of Science ®Google Scholar
• Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012; 156:491–9
   PubMed Web of Science ®Google Scholar
• Morrell S, Barratt A, Irwig L, et al. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography. Cancer Causes Control 2010;21:275–82
   PubMed Web of Science ®Google Scholar
• Sineshaw HM, Gaudet M, Ward EM, et al. Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010–2011). Breast Cancer Res Treat 2014;145:753–63
   PubMed Web of Science ®Google Scholar
• Carter R, Glasziou P, van Oortmarssen G, et al. Cost-effectiveness of mammographic screening in Australia. Aust J Public Health 1993;17:42–50
   PubMedGoogle Scholar
• Australian Government Department of Health and Ageing. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/Content/E158C94C6D5FA028CA25762A00029B8A/$File/cover%20contents.pdf
   Google Scholar
• McPherson K. Screening for breast cancer – balancing the debate. BMJ 2010;340:c3106
   Google Scholar
• Amir E, Bedard PL, Ocana A, et al. Benefits and harms of detecting clinically occult breast cancer. J Natl Cancer Inst 2012;104:1542–7
   PubMed Web of Science ®Google Scholar
• Berry DA. Breast cancer screening: controversy of impact. Breast 2013;22(Suppl 2):S73–6
   Google Scholar
• Duffy SW, Tabar L, Olsen AH, et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010;17:25–30
   PubMed Web of Science ®Google Scholar
• EUROSCREEN Working Group. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. Med Screening 2012;19(Suppl 1):5–13
   PubMedGoogle Scholar
• Barratt A, Howard K, Irwig L, et al. Model of outcomes of screening mammography: information to support informed choices. BMJ 2005;330:936
   PubMed Web of Science ®Google Scholar
• Gøtzsche PC, Hartling OJ , Nielsen M, et al. http://www.cochrane.dk/screening/index-en.htm. 2012
   Google Scholar
• Haybittle JL, Brinkley D, Houghton J, et al. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 1989;298:1611–14
   PubMed Web of Science ®Google Scholar
• Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087–106
   PubMed Web of Science ®Google Scholar
• Nilsson G, Holmberg L, Garmo H, et al. Increased incidence of stroke in women with breast cancer. Eur J Cancer 2005;41: 423–9
   PubMed Web of Science ®Google Scholar
• Nilsson G, Holmberg L, Garmo H, et al. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke. Br J Cancer 2009;100:811–16
   PubMed Web of Science ®Google Scholar
• Lind PA, Pagnanelli R, Marks LB, et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys 2003;55:914–20
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987–98
   PubMed Web of Science ®Google Scholar
• Vaidya JS, Wenz F, Bulsara M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 2014; 383:603–13
   PubMed Web of Science ®Google Scholar
• Tahir M, Hendry P, Baird L, et al. Radiation induced angiosarcoma a sequela of radiotherapy for breast cancer following conservative surgery. Int Semin Surg Oncol 2006;3:26
   PubMedGoogle Scholar
• Sawaya H, Sebag IA, Plana JC, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 2011;107:1375–80
   PubMed Web of Science ®Google Scholar
• Baum M. Harms from breast cancer screening outweigh benefits if death caused by treatment is included. BMJ 2013;346:f385
   PubMed Web of Science ®Google Scholar
• Esserman LJ, Thompson IM, Reid B, et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol 2014;15:e234–42
   PubMed Web of Science ®Google Scholar
• Moynihan R. Science of overdiagnosis to be served up with a good dose of humility. BMJ 2013;347:f5157
   Google Scholar
• Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst 2011;103:1821–6
   PubMed Web of Science ®Google Scholar
• Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2013;310:797–8
   PubMed Web of Science ®Google Scholar
• Dunn BK, Srivastava S, Kramer BS. The word “cancer”: how language can corrupt thought. BMJ 2013;347:f5328
   Google Scholar
• Peres J. New PSA guidelines discourage overscreening. J Natl Cancer Inst 2012;104:8–9
   PubMed Web of Science ®Google Scholar
• Wegwarth O, Gigerenzer G. Less is more: Overdiagnosis and overtreatment: evaluation of what physicians tell their patients about screening harms. JAMA Intern Med 2013;173:2086–7
   PubMed Web of Science ®Google Scholar
• Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502
   PubMed Web of Science ®Google Scholar
• Quanstrum K, Hayward R. Lessons from the mammography wars. N Engl J Med 2010;363:1076–9
   PubMed Web of Science ®Google Scholar
• Woloshin S, Schwartz LM. How a charity oversells mammography. BMJ 2012;345:e5132
   Google Scholar
• Rychetnik L, Carter SM, Abelson J, et al. Enhancing citizen engagement in cancer screening through deliberative democracy. J Natl Cancer Inst 2013;105:380–6
   PubMed Web of Science ®Google Scholar
• Rychetnik L, Carter SM, Barratt A, et al. Expanding the evidence on cancer screening: the value of scientific, social and ethical perspectives. Med J Aust 2013;198:536–9
   PubMed Web of Science ®Google Scholar
• Heath I. Overdiagnosis: when good intentions meet vested interests – an essay by Iona Heath. BMJ 2013;347:f6361
   PubMed Web of Science ®Google Scholar
• Woolf SH, Harris R. The harms of screening: new attention to an old concern. JAMA 2012;307:565–6
   PubMed Web of Science ®Google Scholar
• Hersch J, Jansen J, Barratt A, et al. Women’s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 2013 Jan 23;346:f158
   Google Scholar
• Schwartz LM, Woloshin S, Black WC, et al. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 1997;127:966–72
   PubMed Web of Science ®Google Scholar
• Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Intern Med 2014;174:448–54
   Web of Science ®Google Scholar
• Elmore JG, Fletcher SW. Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm. Ann Intern Med 2012;156:536–7
   PubMed Web of Science ®Google Scholar
• National Health Service. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp.pdf.
   Google Scholar
• Gotzsche PC, Jorgensen KJ. The breast screening programme and misinforming the public. J R Soc Med 2011; 104:361–69
   PubMed Web of Science ®Google Scholar
• Kmietowicz Z. New breast screening leaflet still denies women the full picture, says critic. BMJ 2013;347:f5735
   Google Scholar
• Jorgensen KJ, Gotzsche PC. Content of invitations for publicly funded screening mammography. BMJ 2006;332:538–41
   PubMed Web of Science ®Google Scholar
• Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014; 311:1327–35
   PubMed Web of Science ®Google Scholar
• Hersch J, Jansen J, Irwig L, et al. How do we achieve informed choice for women considering breast screening? Prev Med 2011;53:144–6
   PubMed Web of Science ®Google Scholar
• Elmore JG, Kramer BS. Breast cancer screening: toward informed decisions. JAMA 2014;311:1298–9
   PubMed Web of Science ®Google Scholar
• Hall P, Easton D. Breast cancer screening: time to target women at risk. Br J Cancer 2013;108:2202–4
   PubMed Web of Science ®Google Scholar
• Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 2014;370:1965–7
   PubMed Web of Science ®Google Scholar